Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

abstract

  • Although survival was not improved, arm B offers a better palliation for advanced NSCLC patients than arm A.

publication date

  • January 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.1998.16.6.2133

PubMed ID

  • 9626213

Additional Document Info

start page

  • 2133

end page

  • 41

volume

  • 16

number

  • 6